Gender and estrous cycle effects of the 5-HT1A agonist, 8-OH-DPAT, on hypothalamic serotonin

Pharmacology, Biochemistry, and Behavior
S MaswoodL Uphouse

Abstract

Effects of the 5-HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT; 0.04, 0.25, or 1.0 mg/kg), on hypothalamic serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), and their ratio were determined in adult male rats and in diestrous, proestrous, and estrous female rats. Consistent with its action at the somatodendritic 5-HT1A autoreceptor, 8-OH-DPAT decreased the 5-HIAA/5-HT ratio, but the decrease was least evident in proestrous females and in males. Similar to hypothalamic tissue, there was also a decline in the 5-HIAA/5-HT ratio in the hippocampus after treatment with 0.25 mg/kg 8-OH-DPAT. When ovariectomized rats were treated with oil or estradiol benzoate followed 48 h later by oil or progesterone, 0.25 mg/kg 8-OH-DPAT produced a decrease in the hypothalamic 5-HIAA/5-HT ratio in every group except those rats treated with progesterone without estrogen priming. Treatment with estradiol benzoate increased hypothalamic 5-HIAA, and both progesterone and 8-OH-DPAT reduced the metabolite to the level of the ovariectomized control. These results suggest that both estrogen and progesterone contribute to an estrous cycle modulation of the 5-HT1A somatodendritic autoreceptor.

References

May 15, 1978·European Journal of Pharmacology·D W Gallager
Nov 1, 1992·Pharmacology, Biochemistry, and Behavior·S Salamanca, L Uphouse
Dec 1, 1991·Pharmacology, Biochemistry, and Behavior·J C ShihT Gallaher
Jul 1, 1991·Pharmacology, Biochemistry, and Behavior·L UphouseM Droge
Dec 1, 1991·Pharmacology, Biochemistry, and Behavior·L UphouseM Caldarola-Pastuszka
Jun 11, 1990·Journal of Clinical Psychopharmacology·S W JenkinsL A Reich
Sep 1, 1990·Pharmacology, Biochemistry, and Behavior·A Fernández-Guasti, O Picazo
Jan 1, 1990·Neuroscience and Biobehavioral Reviews·R A Glennon
Nov 1, 1988·Naunyn-Schmiedeberg's Archives of Pharmacology·S Hjorth, T Magnusson
Jul 1, 1989·Pharmacology, Biochemistry, and Behavior·J Williams, L Uphouse
Oct 1, 1982·Neuropharmacology·M E TrulsonC J Frederickson
Sep 10, 1984·Life Sciences·C T FischetteB S McEwen
Apr 1, 1984·Forensic Science International : Synergy·H H HoppeP J Lincoln
Apr 1, 1993·Reviews in the Neurosciences·F G Graeff
Jan 1, 1986·Neurochemistry International·G Curzon

❮ Previous
Next ❯

Citations

Mar 5, 1999·Molecular Neurobiology·C L BetheaZ N Lu
Apr 17, 2013·Pflügers Archiv : European journal of physiology·Nina C Donner, Christopher A Lowry
Nov 27, 2001·Biological Psychiatry·M A Lee, H Y Meltzer
Nov 10, 1998·Biological Psychiatry·D R RubinowC A Roca
Sep 24, 1999·Contraception·C EgarterJ Huber
Sep 25, 1999·European Journal of Pharmacology·U ZippelH Davidowa
Nov 5, 1997·Obstetrics and Gynecology·M SteinerD Streiner
Dec 11, 1999·Pharmacology, Biochemistry, and Behavior·A ParraV M Simón
Sep 30, 2000·Brain Research. Brain Research Reviews·L Uphouse
Nov 14, 2002·Behavioural Brain Research·Santiago MonleónAndrés Parra
Aug 24, 2005·Gender Medicine·Habib U Rehman, Ewan A Masson
Nov 19, 2013·Pharmacology, Biochemistry, and Behavior·Lynda Uphouse
Dec 3, 2008·Behavioural Brain Research·Jantarima PandaranandakaSarinee Kalandakanond-Thongsong
Nov 13, 2009·Annals of the New York Academy of Sciences·Peter J Schmidt, David R Rubinow
Jun 9, 2005·Brain Research. Developmental Brain Research·John M GreavesEfrain C Azmitia
Oct 11, 2012·Pharmacology, Biochemistry, and Behavior·Lynda UphouseCindy Hiegel
Jan 13, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joshua KaufmanChristine DeLorenzo
Jul 15, 2006·Psychoneuroendocrinology·Alonso Fernández-GuastiAnnabel Ferreira
Feb 3, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michelle D Jones, Irwin Lucki
Jan 8, 2005·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Lisa A EckelDeann P D Atchley
Aug 1, 1997·Annals of Medicine·M Brace, E McCauley
May 1, 1999·Journal of Neuroendocrinology·G FlüggeE Fuchs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.